USNA USANA Health Sciences, Inc.
Consumer Defensive$18.26-2.56%ClosedMarket Cap: $337.1M
As of 2026-05-26
Valuation
P/E (TTM)
30.09
PEG
—
P/B
0.63
P/S
0.37
EV/EBITDA
2.52
DCF Value
$90.17
FCF Yield
0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.7%
Operating Margin
5.3%
Net Margin
1.0%
ROE
1.7%
ROA
1.2%
ROIC
1.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $250.2M | 76.2% | $13.9M | $7.5M | $— | — |
| Q4 null | $226.2M | 78.2% | $17.2M | $-1.8M | $— | — |
| FY null | $925.3M | 78.3% | $50.9M | $10.8M | $— | — |
| Q3 null | $213.7M | 77.2% | $1.2M | $-6.5M | $— | — |
| Q2 null | $235.8M | 75.4% | $16.7M | $9.7M | $— | — |
| Q1 null | $249.5M | 75.6% | $15.7M | $9.4M | $— | — |
| Q4 null | $213.6M | 80.1% | $8.2M | $4.5M | $— | — |
| FY null | $854.5M | 79.4% | $66.3M | $42.0M | $— | — |
| Q3 null | $200.2M | 78.6% | $15.6M | $10.6M | $— | — |
| Q2 null | $212.9M | 79.3% | $17.8M | $10.4M | $— | — |
| Q1 null | $227.8M | 79.7% | $24.7M | $16.5M | $— | — |
| Q4 2023 | $221.1M | 79.5% | $24.2M | $16.8M | $0.87 | — |